March 21, 2017
L.A. biotech billionaire Patrick Soon-Shiong
Stories this photo appears in:
NantHealth Inc. announced plans Thursday to lay off about 300 of its staff and sell its provider and patient messaging platform to Allscripts in a move that it expects to save the company more than $70 million annually, according to a filing with the Securities and Exchange Commission.
Biotech billionaire Patrick Soon-Shiong’s plan to build a 7-acre biomedical complex in Phoenix in partnership with the city and Arizona State University is not moving forward, according to local media.
Shares of tronc Inc., parent of the Los Angeles Times, jumped 4.6 percent on Monday after the company pushed back against claims of unfair treatment by Patrick Soon-Shiong, its second-largest shareholder.
The high-stakes chess match for control of tronc Inc., Chicago parent of the Los Angeles Times, reached a fever pitch this week as biotech billionaire Patrick Soon-Shiong upped his stake with a series of stock acquisitions that appeared to be part of a move for control of the company.
L.A. biotech billionaire Patrick Soon-Shiong has upped his stake in Los Angeles Times parent tronc Inc. to 24 percent, nearly overtaking majority shareholder Michael Ferro in a move that may further stoke rumors he could be positioning himself to make a run at the company.